BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae FA, Ng SC, Rubin DT, Christensen B. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther 2020;52:54-72. [PMID: 32348598 DOI: 10.1111/apt.15779] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 26.5] [Reference Citation Analysis]
Number Citing Articles
1 Khan MU, Mushtaq K, Al-Ejji KMAA, Yakoob RA, Alkaabi SR, Khoshnia M. Letter: IBD nurse-a pivotal role in the time of the pandemic. Aliment Pharmacol Ther 2020;52:745. [PMID: 32886392 DOI: 10.1111/apt.15905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bejan CA, Cahill KN, Staso PJ, Choi L, Peterson JF, Phillips EJ. DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing. Clin Pharmacol Ther 2021. [PMID: 34314511 DOI: 10.1002/cpt.2376] [Reference Citation Analysis]
3 Siegel CA, Christensen B, Kornbluth A, Rosh JR, Kappelman MD, Ungaro RC, Johnson DF, Chapman S, Wohl DA, Mantzaris GJ. Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19. J Crohns Colitis. 2020;14:S769-S773. [PMID: 33085972 DOI: 10.1093/ecco-jcc/jjaa135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Aysha AA, Rentsch C, Prentice R, Johnson D, Bryant RV, Ward MG, Costello SP, Lewindon P, Ghaly S, Connor SJ, Begun J, Christensen B. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Intern Med J 2020;50:798-804. [PMID: 32656985 DOI: 10.1111/imj.14889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kuroda N. Decision Making on Telemedicine for Patients With Epilepsy During the Coronavirus Disease 2019 (COVID-19) Crisis. Front Neurol 2020;11:722. [PMID: 32714276 DOI: 10.3389/fneur.2020.00722] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal 2020; 8(5): 383-399 [DOI: 10.13105/wjma.v8.i5.383] [Reference Citation Analysis]
8 Bourgonje AR, van Linschoten RCA, West RL, van Dijk MA, van Leer-Buter CC, Kats-Ugurlu G, Pierik MJ, Festen EAM, Weersma RK, Dijkstra G. Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options. Therap Adv Gastroenterol 2021;14:17562848211012595. [PMID: 33995584 DOI: 10.1177/17562848211012595] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Castro-Sánchez E, Alexander CM, Atchison C, Patel D, Leung W, Calamita ME, Meno Garcia D, Cimpeanu C, Mumbwatasai JM, Ramid D, Doherty K, Grewal HS, Otter JA, Wells EM. Evaluation of a personal protective equipment support programme for staff during the COVID-19 pandemic in London. J Hosp Infect 2021;109:68-77. [PMID: 33307145 DOI: 10.1016/j.jhin.2020.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Din S, Kent A, Pollok RC, Meade S, Kennedy NA, Arnott I, Beattie RM, Chua F, Cooney R, Dart RJ, Galloway J, Gaya DR, Ghosh S, Griffiths M, Hancock L, Hansen R, Hart A, Lamb CA, Lees CW, Limdi JK, Lindsay JO, Patel K, Powell N, Murray CD, Probert C, Raine T, Selinger C, Sebastian S, Smith PJ, Tozer P, Ustianowski A, Younge L, Samaan MA, Irving PM. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut 2020;69:1769-77. [PMID: 32513653 DOI: 10.1136/gutjnl-2020-321927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
11 Rizzello F, Calabrese C, Salice M, Calandrini L, Privitera H, Melotti L, Peruzzi G, Dussias N, Belluzzi A, Scaioli E, Decorato A, Siniscalchi A, Filippone E, Laureti S, Rottoli M, Poggioli G, Gionchetti P. COVID-19 in IBD: The experience of a single tertiary IBD center. Dig Liver Dis. 2021;53:271-276. [PMID: 33451910 DOI: 10.1016/j.dld.2020.12.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
12 Grinevich VB, Gubonina IV, Doshchitsin VL, Kotovskaya YV, Kravchuk YA, Ped VI, Sas EI, Syrov AV, Tarasov AV, Tarzimanova AI, Tkacheva ON, Trukhan DI. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020. Cardiovasc Ther Prev 2020;19:2630. [DOI: 10.15829/1728-8800-2020-2630] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
13 Nørgård BM, Nielsen J, Knudsen T, Nielsen RG, Larsen MD, Jølving LR, Kjeldsen J. Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: A Danish cohort study. Br J Clin Pharmacol 2021;87:2111-20. [PMID: 33098713 DOI: 10.1111/bcp.14622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Privitera G, Pugliese D, Scaldaferri F, Armuzzi A. Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy. Aliment Pharmacol Ther 2021;53:764-5. [PMID: 33599328 DOI: 10.1111/apt.16271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Al Nemer A. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects. Adv Anat Pathol 2020;27:363-70. [PMID: 32732586 DOI: 10.1097/PAP.0000000000000276] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
16 Elli L, Tontini GE, Filippi E, Scaramella L, Cantù P, Vecchi M, Bertè R, Baldassarri A, Penagini R. Efficacy of endoscopic triage during the Covid-19 outbreak and infective risk. Eur J Gastroenterol Hepatol 2020;32:1301-4. [PMID: 32773511 DOI: 10.1097/MEG.0000000000001856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Farkas K, Pigniczki D, Rutka M, Szántó KJ, Resál T, Bor R, Fábián A, Szepes Z, Lázár G, Molnár T. The complex relationship between viruses and inflammatory bowel disease - review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic. Therap Adv Gastroenterol 2021;14:1756284820988198. [PMID: 33953797 DOI: 10.1177/1756284820988198] [Reference Citation Analysis]
18 Bejan CA, Cahill KN, Staso PJ, Choi L, Peterson JF, Phillips EJ. DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19. medRxiv 2021:2021. [PMID: 33564788 DOI: 10.1101/2021.02.04.21251169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Al-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae FA, Ng SC, Rubin DT, Christensen B. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther 2020;52:54-72. [PMID: 32348598 DOI: 10.1111/apt.15779] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 26.5] [Reference Citation Analysis]
20 Roy S, Sheikh SZ, Furey TS. A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD. Sci Rep 2021;11:16522. [PMID: 34389789 DOI: 10.1038/s41598-021-95919-2] [Reference Citation Analysis]
21 Mucino-bermejo M. COVID-19 and the Gastrointestinal Tract. Gastroenterology Insights 2021;12:394-404. [DOI: 10.3390/gastroent12040038] [Reference Citation Analysis]
22 Britton E, Richardson P, Mian I, Conley T, Byrne D, Boyd H, Doherty C, Gupta S, Butt S, Subramanian S. Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Aliment Pharmacol Ther 2020;52:1414-5. [PMID: 33105972 DOI: 10.1111/apt.16061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Chen HY, Wang SI, Chang R, Wei JC. Letter: association between COVID-19 and inflammatory bowel disease. Aliment Pharmacol Ther 2022;55:1226-7. [PMID: 35429026 DOI: 10.1111/apt.16814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kubas A, Malecka-Wojciesko E. COVID-19 Vaccination in Inflammatory Bowel Disease (IBD). J Clin Med 2022;11:2676. [PMID: 35566802 DOI: 10.3390/jcm11092676] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Scharrer S, Kutschera M, Weseslindtner L, Primas C, Vogelsang H. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2021;33:443-7. [PMID: 33522752 DOI: 10.1097/MEG.0000000000002094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Dahiya DS, Kichloo A, Albosta M, Pagad S, Wani F. Gastrointestinal implications in COVID-19. J Investig Med 2020;68:1397-401. [DOI: 10.1136/jim-2020-001559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
27 Im H, Ser J, Sim U, Cho H. Promising Expectations for Pneumococcal Vaccination during COVID-19. Vaccines (Basel) 2021;9:1507. [PMID: 34960253 DOI: 10.3390/vaccines9121507] [Reference Citation Analysis]
28 Ghahramani S, Roozitalab M, Gholami Z, Bagheri Lankarani K. Inflammatory Bowel Disease and COVID-19. Shiraz E-Med J 2020;21. [DOI: 10.5812/semj.106477] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Chebli JMF, Queiroz NSF, Damião AOMC, Chebli LA, Costa MHM, Parra RS. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician. World J Gastroenterol 2021; 27(11): 1022-1042 [PMID: 33776370 DOI: 10.3748/wjg.v27.i11.1022] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
30 Guerra I, Algaba A, Jiménez L, Mar Aller M, Garza D, Bonillo D, Molina Esteban LM, Bermejo F. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. Inflamm Bowel Dis 2021;27:25-33. [PMID: 32830267 DOI: 10.1093/ibd/izaa221] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
31 Lashgari NA, Momeni Roudsari N, Momtaz S, Abdolghaffari AH. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment. World J Gastroenterol 2021; 27(46): 7943-7955 [DOI: 10.3748/wjg.v27.i46.7943] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Al-Ani AH, Johnson D, Christensen B. Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Authors' reply. Aliment Pharmacol Ther 2020;52:921-2. [PMID: 32852806 DOI: 10.1111/apt.15940] [Reference Citation Analysis]
33 Deniz R, Çağatay AA, Gül A. Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Aliment Pharmacol Ther 2020;52:919-20. [PMID: 32852816 DOI: 10.1111/apt.15903] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Salvatori S, Baldassarre F, Mossa M, Monteleone G. Long COVID in Inflammatory Bowel Diseases. J Clin Med 2021;10:5575. [PMID: 34884276 DOI: 10.3390/jcm10235575] [Reference Citation Analysis]
35 Howden CW, Loomba R. A Message from the Editors. Aliment Pharmacol Ther 2022;55:4-5. [PMID: 34907571 DOI: 10.1111/apt.16701] [Reference Citation Analysis]
36 Papa A, Papa V, Lopetuso LR, Gasbarrini A, Tursi A. Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase. Therap Adv Gastroenterol 2020;13:1756284820968747. [PMID: 33149764 DOI: 10.1177/1756284820968747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J 2021. [PMID: 34190413 DOI: 10.1002/ueg2.12115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 De Lima-Karagiannis A, Juillerat P, Sebastian S, Pedersen N, Bar-Gil Shitrit A, van der Woude CJ. Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic. J Crohns Colitis. 2020;14:S807-S814. [PMID: 33085970 DOI: 10.1093/ecco-jcc/jjaa125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Spagnuolo R, Larussa T, Iannelli C, Cosco C, Nisticò E, Manduci E, Bruno A, Boccuto L, Abenavoli L, Luzza F, Doldo P. COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey. Medicina (Kaunas) 2020;56:E407. [PMID: 32823727 DOI: 10.3390/medicina56080407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020;51:1434-1437. [PMID: 32311755 DOI: 10.1111/apt.15777] [Cited by in Crossref: 151] [Cited by in F6Publishing: 132] [Article Influence: 75.5] [Reference Citation Analysis]
41 Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Civitelli F, Corsello A, D'Arcangelo G, Dilillo A, Dipasquale V, Felici E, Fuoti M, Gatti S, Giusti Z, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Nuti F, Panceri R, Rampado S, Renzo S, Romano C, Romeo E, Strisciuglio C, Martinelli M. Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group. Dig Liver Dis. 2021;53:183-189. [PMID: 33132063 DOI: 10.1016/j.dld.2020.10.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:107602962110566. [DOI: 10.1177/10760296211056648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Day AS, Wood JA, Halmos EP, Bryant RV. Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. J Acad Nutr Diet 2021;121:201-9. [PMID: 32855101 DOI: 10.1016/j.jand.2020.07.019] [Reference Citation Analysis]
44 Garg M, Al-Ani A, Mitchell H, Hendy P, Christensen B. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North-supports vitamin D as a factor determining severity. Authors' reply. Aliment Pharmacol Ther 2020;51:1438-9. [PMID: 32352178 DOI: 10.1111/apt.15796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
45 Iborra I, Puig M, Marín L, Calafat M, Cañete F, Quiñones C, González-González L, Cardona G, Mañosa M, Domènech E. Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic. Dig Dis Sci 2021. [PMID: 33469807 DOI: 10.1007/s10620-020-06807-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Feitosa MR, Parra RS, de Camargo HP, Ferreira SDC, Troncon LEA, da Rocha JJR, Féres O. COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil. Ann Gastroenterol 2021;34:39-45. [PMID: 33414620 DOI: 10.20524/aog.2020.0558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Kale A, Shinde L, Sundaram S, Patra BR, Rao PK, Irtaza M, Shukla A. COVID-19 pandemic and inflammatory bowel disease from patients' perspective: A survey from COVID epicenter in India. JGH Open 2022;6:126-31. [PMID: 35155822 DOI: 10.1002/jgh3.12686] [Reference Citation Analysis]
48 Al-Ani AH, Rentsch CA, Azim S, Bidgood E, Onasseril P, Christensen B. Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply. Aliment Pharmacol Ther 2020;52:746-7. [PMID: 32886366 DOI: 10.1111/apt.15954] [Reference Citation Analysis]
49 Prentice RE, Al-Ani A, Christensen B. Managing COVID-19 in patients with inflammatory bowel disease: navigating unprecedented challenges. Intern Med J 2021;51:284-7. [PMID: 33631857 DOI: 10.1111/imj.15190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]